Showing results (241-250 of 4,703) with videos related to

Sort By:
Pageof 471
Therapeutic Drug Monitoring|July 27, 2005
The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipientsMateusz Kurzawski, Krzysztof Dziewanowski, Barbara Gawrońska-Szklarz, et al.
Therapeutic Drug Monitoring|July 27, 2005
Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA)François Parant, Mustapha Moulsma, Marie Claude Gagnieu, et al.
Therapeutic Drug Monitoring|July 27, 2005
Assay of olanzapine in human plasma by a rapid and sensitive gas chromatography-nitrogen phosphorus selective detection (GC-NPD) method: validation and comparison with high-performance liquid chromatography-coulometric detectionSven Ulrich
Therapeutic Drug Monitoring|July 27, 2005
Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder: a 6-month therapeutic drug monitoring studyMargareta Reis, Jiri Prochazka, Ad Sitsen, et al.
Therapeutic Drug Monitoring|July 27, 2005
Resistance to aspirin in patients after coronary artery bypass grafting is transient: impact on the monitoring of aspirin antiplatelet therapyJacek Golański, Stefan Chłopicki, Ryszard Golański, et al.
Therapeutic Drug Monitoring|July 27, 2005
MDR1 genetic polymorphisms and comparison of MDR1 haplotype profiles in Korean and Vietnamese populationsSang Seop Lee, So-Young Kim, Woo-Young Kim, et al.
Therapeutic Drug Monitoring|July 27, 2005
Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patientsGuido Bondolfi, Françoise Morel, Séverine Crettol, et al.
Therapeutic Drug Monitoring|January 1, 1987
Dual effects of carbamazepine-phenytoin interactionJ J Zielinski, D Haidukewych
Therapeutic Drug Monitoring|January 16, 2023
Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic ApproachJoseph Piscitelli, Mina Nikanjam, Edmund V Capparelli, et al.
Therapeutic Drug Monitoring|January 17, 2023
Quantification of the Conjugated Forms of Dichlorobisphenol A (3,3'-Cl 2 BPA) in Rat and Human Plasma Using HPLC-MS/MSNoemie Plattard, Riciga Gnanasegaran, Aida Krekesheva, et al.
Pageof 471